Ciprofloxacin interferes with Salmonella Typhimurium intracellular survival and host virulence through repression of Salmonella pathogenicity island-2 (SPI-2) genes expression.
暂无分享,去创建一个
[1] T. Dallman,et al. Emergence of phylogenetically diverse and fluoroquinolone resistant Salmonella Enteritidis as a cause of invasive nontyphoidal Salmonella disease in Ghana , 2019, PLoS neglected tropical diseases.
[2] L. J. Mota,et al. SsaV Interacts with SsaL to Control the Translocon-to-Effector Switch in the Salmonella SPI-2 Type Three Secretion System , 2018, mBio.
[3] Nora C. Toussaint,et al. Genomic and Geographic Context for the Evolution of High-Risk Carbapenem-Resistant Enterobacter cloacae Complex Clones ST171 and ST78 , 2018, mBio.
[4] A. Aseffa,et al. Molecular epidemiology of fluoroquinolone resistant Salmonella in Africa: A systematic review and meta-analysis , 2018, PloS one.
[5] Hong-Xia Jiang,et al. Resistance mechanisms and fitness of Salmonella Typhimurium and Salmonella Enteritidis mutants evolved under selection with ciprofloxacin in vitro , 2017, Scientific Reports.
[6] B. Finlay,et al. What the SIF Is Happening—The Role of Intracellular Salmonella-Induced Filaments , 2017, Front. Cell. Infect. Microbiol..
[7] J. Capelo,et al. Comparative subproteomic analysis of clinically acquired fluoroquinolone resistance and ciprofloxacin stress in Salmonella Typhimurium DT104B , 2017, Proteomics. Clinical applications.
[8] L. Good,et al. Targeting the hard to reach: challenges and novel strategies in the treatment of intracellular bacterial infections , 2017, British journal of pharmacology.
[9] X. Jiao,et al. Influence of Salmonella enterica serovar Pullorum pathogenicity island 2 on type III secretion system effector gene expression in chicken macrophage HD11 cells , 2017, Avian pathology : journal of the W.V.P.A.
[10] C. MacLennan,et al. A Systematic Review of the Incidence, Risk Factors and Case Fatality Rates of Invasive Nontyphoidal Salmonella (iNTS) Disease in Africa (1966 to 2014) , 2017, PLoS neglected tropical diseases.
[11] S. Kim,et al. Analysis of the Fluoroquinolone Antibiotic Resistance Mechanism of Salmonella enterica Isolates. , 2016, Journal of microbiology and biotechnology.
[12] I. Contreras,et al. Exposure to sub-inhibitory concentrations of cefotaxime enhances the systemic colonization of Salmonella Typhimurium in BALB/c mice , 2015, Open Biology.
[13] Christopher M. Parry,et al. Antimicrobial Resistance , and Antimicrobial Management of Invasive Salmonella Infections , 2015 .
[14] J. Turnidge,et al. Susceptibility Test Methods: Dilution and Disk Diffusion Methods* , 2015 .
[15] A. Berndt,et al. Immune Reaction and Survivability of Salmonella Typhimurium and Salmonella Infantis after Infection of Primary Avian Macrophages , 2015, PloS one.
[16] Youngjoo Byun,et al. 6-Gingerol reduces Pseudomonas aeruginosa biofilm formation and virulence via quorum sensing inhibition , 2015, Scientific Reports.
[17] Christopher C. Overall,et al. Analysis of the Salmonella regulatory network suggests involvement of SsrB and H-NS in σE-regulated SPI-2 gene expression , 2015, Front. Microbiol..
[18] Daofeng Liu,et al. Effective cancer vaccine platform based on attenuated salmonella and a type III secretion system. , 2014, Cancer research.
[19] Diarmaid Hughes,et al. Microbiological effects of sublethal levels of antibiotics , 2014, Nature Reviews Microbiology.
[20] M. Maksoud,et al. Multi-drug resistance and reduced susceptibility to ciprofloxacin among Salmonella enterica serovar Typhi isolates from the Middle East and Central Asia , 2014, New microbes and new infections.
[21] J. Fierer,et al. Diarrhea and Colitis in Mice Require the Salmonella Pathogenicity Island 2-Encoded Secretion Function but Not SifA or Spv Effectors , 2012, Infection and Immunity.
[22] R. Black,et al. Typhoid fever and paratyphoid fever: Systematic review to estimate global morbidity and mortality for 2010 , 2012, Journal of global health.
[23] M. Hensel,et al. Divergent Roles of Salmonella Pathogenicity Island 2 and Metabolic Traits during Interaction of S. enterica Serovar Typhimurium with Host Cells , 2012, PloS one.
[24] M. Hensel,et al. Evaluation of Salmonella enterica Type III Secretion System Effector Proteins as Carriers for Heterologous Vaccine Antigens , 2012, Infection and Immunity.
[25] M. Hensel,et al. Salmonella enterica as a vaccine carrier. , 2012, Future microbiology.
[26] G. Menezes,et al. Antimicrobial resistance in typhoidal salmonellae. , 2011, Indian journal of medical microbiology.
[27] J. Vila,et al. Repression of Invasion Genes and Decreased Invasion in a High-Level Fluoroquinolone-Resistant Salmonella Typhimurium Mutant , 2009, PloS one.
[28] M. Hensel,et al. Systematic Analysis of the SsrAB Virulon of Salmonella enterica , 2009, Infection and Immunity.
[29] H. Lillehoj,et al. Induction of CXC Chemokine Messenger-RNA Expression in Chicken Oviduct Epithelial Cells by Salmonella enterica Serovar Enteritidis via the Type Three Secretion System–1 , 2009, Avian diseases.
[30] H. Lillehoj,et al. Functions exerted by the virulence-associated type-three secretion systems during Salmonella enterica serovar Enteritidis invasion into and survival within chicken oviduct epithelial cells and macrophages , 2009, Avian pathology : journal of the W.V.P.A.
[31] J. Pagés,et al. Multiple Regulatory Pathways Associated with High-Level Ciprofloxacin and Multidrug Resistance in Salmonella enterica Serovar Enteritidis: Involvement of ramA and Other Global Regulators , 2008, Antimicrobial Agents and Chemotherapy.
[32] J. Fierer,et al. Identification of Salmonella SPI-2 secretion system components required for SpvB-mediated cytotoxicity in macrophages and virulence in mice. , 2008, FEMS immunology and medical microbiology.
[33] M. Hensel,et al. Salmonella pathogenicity islands in host specificity, host pathogen-interactions and antibiotics resistance of Salmonella enterica. , 2007, Berliner und Munchener tierarztliche Wochenschrift.
[34] F. Baquero,et al. Antibiotics as intermicrobial signaling agents instead of weapons , 2006, Proceedings of the National Academy of Sciences.
[35] G. Cornelis,et al. The type III secretion injectisome , 2006, Nature Reviews Microbiology.
[36] J. Galán,et al. Manipulation of the host actin cytoskeleton by Salmonella--all in the name of entry. , 2005, Current opinion in microbiology.
[37] M. Hensel,et al. Cellular microbiology of intracellular Salmonella enterica: functions of the type III secretion system encoded by Salmonella pathogenicity island 2 , 2004, Cellular and Molecular Life Sciences CMLS.
[38] J. Rotschafer,et al. Application of fluoroquinolone pharmacodynamics. , 2000, The Journal of antimicrobial chemotherapy.
[39] Sezgin Erdoğan,et al. Environmental regulation of Salmonella pathogenicity island 2 gene expression , 1999, Molecular microbiology.
[40] S. Falkow,et al. Functional analysis of ssaJ and the ssaK/U operon, 13 genes encoding components of the type III secretion apparatus of Salmonella Pathogenicity Island 2 , 1997, Molecular microbiology.
[41] T. Whittam,et al. Molecular genetic relationships of the salmonellae , 1996, Applied and environmental microbiology.
[42] J. Pocidalo. Use of fluoroquinolones for intracellular pathogens. , 1989, Reviews of infectious diseases.
[43] J. Crane,et al. Effect of ciprofloxacin on intracellular organisms: in-vitro and in-vivo studies. , 1986, The Journal of antimicrobial chemotherapy.